A Survey of Products Licensed in the United Kingdom from 1971-1981
Overview
Authors
Affiliations
The need for pharmacoeconomic evaluations in the NHS.
Griffin J Pharmacoeconomics. 1998; 14(3):241-50.
PMID: 10186463 DOI: 10.2165/00019053-199814030-00001.
Therapeutic conservatism: more costly in the long term? A UK perspective.
Griffin J Pharmacoeconomics. 1995; 7(5):378-87.
PMID: 10155325 DOI: 10.2165/00019053-199507050-00002.
U.K. drug control: retrospect and prospect.
Binns T Br J Clin Pharmacol. 1981; 12(4):449-51.
PMID: 7295481 PMC: 1401911. DOI: 10.1111/j.1365-2125.1981.tb01250.x.
Ten years of The Medicines Act.
GOLDBERG A Br J Clin Pharmacol. 1981; 12(4):447-8.
PMID: 7295480 PMC: 1401904. DOI: 10.1111/j.1365-2125.1981.tb01249.x.
The role of the pharmaceutical industry in diabetes research.
LOVATT G Diabetologia. 1982; 23(3):216-9.
PMID: 7128970 DOI: 10.1007/BF00252844.